Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer

M. H. Cohen, R. Makuch, A. Johnston-Early, D. C. Ihde, P. A. Bunn, B. E. Fossieck, J. D. Minna

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Pretreatment performance status (PS) is a major prognostic factor for both treatment response and survival duration in cancer clinical trials. PS is, however, a subjective index that may be markedly influenced by acute self-limited events. The objective of this study was to develop a prognostic index, based on pretreatment laboratory results, that might serve as an alternative to PS in patients with small cell anaplastic lung cancer. Results have been analyzed in 56 newly diagnosed patients with a minimum followup of 10 months and a median followup of 21 months. Patients were divided into high and low groups for each laboratory parameter based on readings either above or below the median value. Patients with high hemoglobin or albumin levels or low serum alpha-1 globulins, gamma globulins, or LDH survived significantly longer than patients with the opposite levels. When these factors were evaluated by multivariate analysis, albumin and hemoglobin were the most influential prognostic factors for survival. After inclusion of these two laboratory parameters, PS was no longer a significant prognosticator of survival. An objective prognostic index based on pretreatment laboratory results appears feasible in patients with small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalCancer Treatment Reports
Volume65
Issue number3-4
StatePublished - 1981

Fingerprint

Small Cell Lung Carcinoma
Survival
Albumins
Hemoglobins
gamma-Globulins
Reading
Multivariate Analysis
Clinical Trials
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cohen, M. H., Makuch, R., Johnston-Early, A., Ihde, D. C., Bunn, P. A., Fossieck, B. E., & Minna, J. D. (1981). Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treatment Reports, 65(3-4), 187-195.

Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. / Cohen, M. H.; Makuch, R.; Johnston-Early, A.; Ihde, D. C.; Bunn, P. A.; Fossieck, B. E.; Minna, J. D.

In: Cancer Treatment Reports, Vol. 65, No. 3-4, 1981, p. 187-195.

Research output: Contribution to journalArticle

Cohen, MH, Makuch, R, Johnston-Early, A, Ihde, DC, Bunn, PA, Fossieck, BE & Minna, JD 1981, 'Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer', Cancer Treatment Reports, vol. 65, no. 3-4, pp. 187-195.
Cohen, M. H. ; Makuch, R. ; Johnston-Early, A. ; Ihde, D. C. ; Bunn, P. A. ; Fossieck, B. E. ; Minna, J. D. / Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. 3-4. pp. 187-195.
@article{68955d23143a476d83f328af4a0f5d93,
title = "Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer",
abstract = "Pretreatment performance status (PS) is a major prognostic factor for both treatment response and survival duration in cancer clinical trials. PS is, however, a subjective index that may be markedly influenced by acute self-limited events. The objective of this study was to develop a prognostic index, based on pretreatment laboratory results, that might serve as an alternative to PS in patients with small cell anaplastic lung cancer. Results have been analyzed in 56 newly diagnosed patients with a minimum followup of 10 months and a median followup of 21 months. Patients were divided into high and low groups for each laboratory parameter based on readings either above or below the median value. Patients with high hemoglobin or albumin levels or low serum alpha-1 globulins, gamma globulins, or LDH survived significantly longer than patients with the opposite levels. When these factors were evaluated by multivariate analysis, albumin and hemoglobin were the most influential prognostic factors for survival. After inclusion of these two laboratory parameters, PS was no longer a significant prognosticator of survival. An objective prognostic index based on pretreatment laboratory results appears feasible in patients with small cell lung cancer.",
author = "Cohen, {M. H.} and R. Makuch and A. Johnston-Early and Ihde, {D. C.} and Bunn, {P. A.} and Fossieck, {B. E.} and Minna, {J. D.}",
year = "1981",
language = "English (US)",
volume = "65",
pages = "187--195",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3-4",

}

TY - JOUR

T1 - Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer

AU - Cohen, M. H.

AU - Makuch, R.

AU - Johnston-Early, A.

AU - Ihde, D. C.

AU - Bunn, P. A.

AU - Fossieck, B. E.

AU - Minna, J. D.

PY - 1981

Y1 - 1981

N2 - Pretreatment performance status (PS) is a major prognostic factor for both treatment response and survival duration in cancer clinical trials. PS is, however, a subjective index that may be markedly influenced by acute self-limited events. The objective of this study was to develop a prognostic index, based on pretreatment laboratory results, that might serve as an alternative to PS in patients with small cell anaplastic lung cancer. Results have been analyzed in 56 newly diagnosed patients with a minimum followup of 10 months and a median followup of 21 months. Patients were divided into high and low groups for each laboratory parameter based on readings either above or below the median value. Patients with high hemoglobin or albumin levels or low serum alpha-1 globulins, gamma globulins, or LDH survived significantly longer than patients with the opposite levels. When these factors were evaluated by multivariate analysis, albumin and hemoglobin were the most influential prognostic factors for survival. After inclusion of these two laboratory parameters, PS was no longer a significant prognosticator of survival. An objective prognostic index based on pretreatment laboratory results appears feasible in patients with small cell lung cancer.

AB - Pretreatment performance status (PS) is a major prognostic factor for both treatment response and survival duration in cancer clinical trials. PS is, however, a subjective index that may be markedly influenced by acute self-limited events. The objective of this study was to develop a prognostic index, based on pretreatment laboratory results, that might serve as an alternative to PS in patients with small cell anaplastic lung cancer. Results have been analyzed in 56 newly diagnosed patients with a minimum followup of 10 months and a median followup of 21 months. Patients were divided into high and low groups for each laboratory parameter based on readings either above or below the median value. Patients with high hemoglobin or albumin levels or low serum alpha-1 globulins, gamma globulins, or LDH survived significantly longer than patients with the opposite levels. When these factors were evaluated by multivariate analysis, albumin and hemoglobin were the most influential prognostic factors for survival. After inclusion of these two laboratory parameters, PS was no longer a significant prognosticator of survival. An objective prognostic index based on pretreatment laboratory results appears feasible in patients with small cell lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0019426496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019426496&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 187

EP - 195

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3-4

ER -